"Payviders" are responsible for the cost of avoidable readmissions and emergency room visits, but they lose sight of patients once they go home.
|Articles|December 25, 2022
Most-Read Conference Coverage of 2022
Author(s)Briana Contreras
Conference season was a busy one this year with many stories to come out each one MHE covered. The most-read conference stories from our audience began with Atopic Dermatitis treatment at AMCP to discussion series with PBM leader Alan Lotvin of CVS Caremark.
Advertisement
- AMCP 2022: Atopic Dermatitis Treatment is a Good News Story, Say Symposium Panelists
Dupixent (dupilumab) ushered in a new era and a growing number of treatment options has brought awareness to the condition. But the panelists also discussed problems with step therapy, delays and denials of treatment and the lack of a “gold standard” test for diagnosis.Read more - Weight-Loss Drugs: Why This Time It May Be a Different Story | 2022 PBMI Annual National Conference
The harm caused by weight-loss drugs have overwhelmed any benefit they may have. The repurposed diabetes drugs like Wegovy (semaglutide) have a strong safety profile, said presented at the annual Pharmacy Benefit Management Institute meeting.Read more - Specialty Pharmacy Controls Limit Patient Access, Fein and Long Explain: 2022 Asembia Specialty Pharmacy Summit
In their general session, Adam J. Fein, PhD of Drug Channels Institute, and Doug Long of IQVIA reviewed the current specialty pharmacy space, ongoing trends and future expectations.Read more - 2022 PBMI National Meeting Kicks Off Monday
Agenda includes sessions on overall trends in the pharmacy benefit management industry, digital therapeutics and biosimilars.Read more - A Conversation with Alan Lotvin, M.D. on the PBM Industry’s Reputation | Part 1
The president of CVS Caremark discusses the PBM industry’s reputation, list prices and rebates.Read more
Advertisement
Related to this article
Jenny Goins, interim head of the National Alliance of Healthcare Purchaser Coalitions, says employers need the same visibility into medical benefits that a new Department of Labor rule gives them into PBM compensation.
Only 19% of community oncologists use AI predictive models. Prerna Mewawalla, M.D., outlines six ways AI can already help in myeloma care.
Jamilia Sherls, DNP, says health systems should track vaccine coverage closely and look to AAP schedules if federal guidance isn't evidence-based.
Model N's Jesse Mendelsohn explains why drug manufacturers argued that a 340B rebates instead of upfront discounts will avoid an overlapping maximum fair price and 340B discounts
People with ADHD had a 70% higher risk of death from any cause in a 19-study meta-analysis, with excess deaths from suicide, injury and natural causes.
Bronchiectasis affected 221.6 per 100,000 people in the U.S. over five years, which is higher than earlier national estimates, according to a study published in CHEST.
Cepheid’s Xpert Respiratory Panel, which tests one swab for nine viruses and four bacteria, is now certified for sale in Europe under the IVDR.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Six jobs for AI in myeloma care, from Prerna Mewawalla, M.D.
2
Vaccine schedule overhaul could put coverage at risk, state official says
3
Bronchiectasis is more common in the U.S. than a decade ago, study finds
4
Quick Q&A: Christopher Stanley, M.D., MBA, on population health and healthcare affordability
5